title: Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
authors.affiliation: Department of Adult Reconstructive Surgery, Henry Ford Hospital, Orthopaedic Surgery, Detroit, Michigan.
authors.forename: Wayne T
authors.initials: WT
authors.lastname: North
authors.affiliation: Department of Adult Reconstructive Surgery, Henry Ford Hospital, Orthopaedic Surgery, Detroit, Michigan.
authors.forename: Nima
authors.initials: N
authors.lastname: Mehran
authors.affiliation: Department of Adult Reconstructive Surgery, Henry Ford Hospital, Orthopaedic Surgery, Detroit, Michigan.
authors.forename: Jason J
authors.initials: JJ
authors.lastname: Davis
authors.affiliation: Department of Adult Reconstructive Surgery, Henry Ford Hospital, Orthopaedic Surgery, Detroit, Michigan.
authors.forename: Craig D
authors.initials: CD
authors.lastname: Silverton
authors.affiliation: Department of Adult Reconstructive Surgery, Henry Ford Hospital, Orthopaedic Surgery, Detroit, Michigan.
authors.forename: Robb M
authors.initials: RM
authors.lastname: Weir
authors.affiliation: Department of Adult Reconstructive Surgery, Henry Ford Hospital, Orthopaedic Surgery, Detroit, Michigan.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Laker
mesh_terms: D000287:Administration, Topical; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip; D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D004311:Double-Blind Method; D006801:Humans; D019106:Postoperative Hemorrhage; D014148:Tranexamic Acid / Q000627:therapeutic use*
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid